Blue Cross Blue Shield of North Dakota regularly develops and revises medical policies in response to rapidly changing medical technology. Our commitment is to update the provider community as medical policies are adopted and/or revised. Benefit determinations are made based on the medical policy in effect at the time of service.
The following medical policies were reviewed by the Internal Medical Policy Committee on November 14, 2019. Please see policy for changes. Medical policies are available at www.bcbsnd.com/web/providers/policies.
The following policies are new or have been revised:
Hematopoietic Cell Transplant for Miscellaneous Solid tumors in Adults
Hematopoietic Cell Transplant for Solid Tumors of Childhood
Hematopoietic Cell Transplant for Primary Amyloidosis
Homocysteine Testing in the Screening, Diagnosis, and Management of Cardiovascular Disease and Venous Thromboembolic Disease
Autografts and Allografts in the Treatment of Focal Articular Cartilage Lesions
Diagnosis and Treatment of Obstructive Sleep Apnea in Children
Myoelectric Prosthetic Components for Upper Limb
Electrical Bone Growth Stimulators